In hepatocellular carcinoma (HCC), the glycosyltransferase GALNT14 mediates O-glycosylation of PHB2, enhancing tumor cell proliferation, migration, and chemotherapy resistance through activation of the insulin-like growth factor 1 receptor (IGF1R) signaling cascade [357]. Here, PHB2 is linked to hepatocellular carcinoma.